5-HYDROXYTRYPTAMINE RECEPTOR 4

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Tue Apr 01 17:59:35 GMT 2025` Edited by `admin` on `Tue Apr 01 17:59:35 GMT 2025`
Protein Type	RECEPTOR
Protein Sub Type
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	7H1P16DG5J
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

5-HT4

Preferred Name

English

5-HYDROXYTRYPTAMINE RECEPTOR 4

Common Name

English

SEROTONIN RECEPTOR 4

Common Name

English

HTR4

Common Name

English

Code System Code Type Description

FDA UNII

7H1P16DG5J

Created by admin on Tue Apr 01 17:59:35 GMT 2025 , Edited by admin on Tue Apr 01 17:59:35 GMT 2025

PRIMARY

UNIPROT

Q13639

Created by admin on Tue Apr 01 17:59:35 GMT 2025 , Edited by admin on Tue Apr 01 17:59:35 GMT 2025

PRIMARY

From	To
1_93	1_184

Glycosylation Type

HUMAN

Glycosylation Link Type	Site
N	1_7

Related Record Type Details


					8163770L8P

CAPESEROD

PARTIAL AGONIST->TARGET

Amount:


					QWZ4KZ6JHE

SB-207710

INHIBITOR -> TARGET

Comments:

Kb listed

Qualification:

Kd

Amount:


					NLN26F8BPQ

SB-207145

INHIBITOR -> TARGET

Qualification:

Ki

Amount:


					VFA59J8C89

E-3620 FREE BASE

AGONIST -> TARGET

Amount:


					I7V9UD0ND0

AGONIST -> TARGET

Amount:


					458VC51857

TEGASEROD

AGONIST -> TARGET

Amount:


					838F01T721

INHIBITOR -> TARGET

Interaction Type:

INHIBITOR

Qualification:

Ki

Amount:


					73EBX462X5

INHIBITOR -> TARGET

Amount:


					0A09IUW5TP

AGONIST -> TARGET

Comments:

Interaction with the 5-HT4 receptor leads to the elevation of cyclic adenosine monophosphate (cAMP) levels in HEK293 cells

Qualification:

EC50

Amount:


					F6RJL8B278

NON-INHIBITOR -> TRANSPORTER

Qualification:

Ki

Amount:


					35F0Y2W16Q

AGONIST -> TARGET

Interaction Type:

BINDING

Qualification:

Ki

Amount:


					HXB2NJ4ZGG

SB-207710 I-123

RADIOLIGAND->TARGET

Qualification:

Kd

Amount:


					7QGN8QXG7I

PRX-03140

PARTIAL AGONIST->TARGET

Amount:


					38126EQF7A

ZACOPRIDE, (R)-

AGONIST -> TARGET

Amount:


					L6UH7ZF8HC

WEAK INHIBITOR->TARGET

Interaction Type:

INHIBITOR

Qualification:

Ki

Amount:


					Y22GRV2JAZ

SB-207710 I-125

RADIOLIGAND->TARGET

Qualification:

Kd

Amount:


					4UQ3S81B25

PIBOSEROD

INHIBITOR -> TARGET

Amount:


					N33SZ2N85M

AGONIST -> TARGET

Amount:


					SIS5BFO4WL

AGONIST -> TARGET

Amount:

058896B00B

AGONIST -> TARGET

Amount:


					QNG273A81O

NORCISAPRIDE, (+)-

AGONIST -> TARGET

Amount:


					0ZN0AQ6SBV

TD-2749

AGONIST -> TARGET

Interaction Type:

BINDING

Qualification:

Ki

Amount:


					GNQ25KYD72

AGONIST -> TARGET

Interaction Type:

PARTIAL AGONIST

Amount:


					J4VNV64ARB

AGONIST -> TARGET

Amount:


					9073C0W4E9

PARTIAL AGONIST->TARGET

Comments:

Has about 50% of the activity of serotonin

Qualification:

Ki

Amount:


					KZ4Z7737KU

RADIOLIGAND->TARGET

Comments:

IMAGING AGENT

Qualification:

Ki

Amount:


					8C63R2Y02M

AGONIST -> TARGET

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT	CHEMICAL
Molecular Formula	CHEMICAL